Mineralys Therapeutics (MLYS) Equity Ratio (2022 - 2026)
Quarterly results put Equity Ratio at 0.98 for Q1 2026, up 1.58% from a year ago — trailing twelve months through Mar 2026 was 0.98 (up 1.58% YoY), and the annual figure for FY2025 was 0.98, up 5.2%.
Mineralys Therapeutics has reported Equity Ratio over the past 5 years, most recently at 0.98 for Q1 2026.
- Equity Ratio reached 0.98 in Q1 2026 per MLYS's latest filing, roughly flat from 0.98 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.98 in Q2 2023 and bottomed at 0.46 in Q4 2022.
- Median Equity Ratio over the past 5 years was 0.95 (2023), compared with a mean of 0.85.
- The largest annual shift saw Equity Ratio soared 309.83% in 2023 before it decreased 7.15% in 2024.
- Over 5 years, Equity Ratio stood at 0.46 in 2022, then soared by 309.83% to 0.96 in 2023, then decreased by 3.08% to 0.93 in 2024, then rose by 5.2% to 0.98 in 2025, then rose by 0.03% to 0.98 in 2026.
- Business Quant data shows Equity Ratio for MLYS at 0.98 in Q1 2026, 0.98 in Q4 2025, and 0.96 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.73 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.77 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.21 |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | 0.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.98 |
| Dec 31, 2025 | 0.98 |
| Sep 30, 2025 | 0.96 |
| Jun 30, 2025 | 0.93 |
| Mar 31, 2025 | 0.96 |
| Dec 31, 2024 | 0.93 |
| Sep 30, 2024 | 0.88 |
| Jun 30, 2024 | 0.91 |
| Mar 31, 2024 | 0.94 |
| Dec 31, 2023 | 0.96 |
| Sep 30, 2023 | 0.95 |
| Jun 30, 2023 | 0.98 |
| Mar 31, 2023 | 0.97 |
| Dec 31, 2022 | -0.46 |